{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Nastorazepide_Calcium",
  "nciThesaurus": {
    "casRegistry": "343326-69-2",
    "chebiId": "",
    "chemicalFormula": "",
    "definition": "A selective, orally available, 1,5-benzodiazepine-derivative gastrin/cholecystokinin 2 (CCK-2) receptor antagonist with potential antineoplastic activity. Z-360 binds to the gastrin/CCK-2 receptor, thereby preventing receptor activation by gastrin, a peptide hormone frequently associated with the proliferation of gastrointestinal and pancreatic tumor cells.",
    "fdaUniiCode": "GZ3I1DMI8Q",
    "identifier": "C61329",
    "preferredName": "Nastorazepide Calcium",
    "semanticType": "Pharmacologic Substance",
    "subclassOf": [
      "C129824"
    ],
    "synonyms": [
      "Gastrin/cholecystokinin Type B Receptor Inhibitor Z-360",
      "NASTORAZEPIDE CALCIUM",
      "Nastorazepide Calcium",
      "Z-360"
    ]
  }
}